Researchers find no difference in health worker infections from flu, other viruses.
President Trump yesterday signed bipartisan legislation reauthorizing the Pandemic and All-Hazards Preparedness and Advancing Innovations Act (PAHPA), which plays a crucial role in preparing the country for natural or manmade biological threats such as pandemic flu or a bioterror attack.
The Centers for Disease Control and Prevention (CDC) said today it has wrapped up its investigation into a Salmonella Concord outbreak tied to tahini imported from Israel after eight cases were confirmed in four states.
Saudi Arabia's Ministry of Health (MOH) reported another case of MERS-CoV today, this time in a man who had contact with camels.
In an update to its epidemiologic week 5 report, the MOH said the patient was a 65-year-old man from Buraydah. He is hospitalized for his MERS-CoV (Middle East respiratory syndrome coronavirus) infection.
Ebola infections have been confirmed in 12 more people in the Democratic Republic of the Congo (DRC), including 6 in Katwa, one of the more recent hot spots, the country's health ministry said today.
A Salmonella Newport outbreak linked to tainted ground beef products has sickened 87 more people, raising the outbreak total to 333 people in 28 states, the Centers for Disease Control and Prevention (CDC) said today in an update.
An analysis of Puerto Rican Zika patients who had thrombocytopenia, a rare complication, found that, in those with the severest cases, immune treatments may be more effective than platelet transfusion. A team from the US Centers for Disease Control and Prevention (CDC) and Puerto Rico reported its findings today in Open Forum Infectious Diseases.
The US Centers for Disease Control and Prevention (CDC) today said it and state health partners are investigating 28 more suspected acute flaccid myelitis (AFM) cases, lifting the national number of suspected cases for 2018 to 219.
The experts also called for 3 new pandemic candidate vaccine viruses.
Public Health England (PHE) yesterday released its provisional seasonal flu vaccine effectiveness (VE) estimates for the 2017-18 flu season, which revealed low overall effectiveness and no protection against H3N2, but variable findings in different age-groups.